Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Impaired cellular immunity to SARS-CoV-2 in severe COVID-19 patients

Ling Ni, Meng-Li Cheng, Hui Zhao, Yu Feng, Jingyuan Liu, Fang Ye, Qing Ye, Gengzhen Zhu, Xiaoli Li, Pengzhi Wang, Jing Shao, Yong-Qiang Deng, Peng Wei, Fang Chen, Cheng-Feng Qin, Guoqing Wang, Fan Li, Hui Zeng, Chen Dong
doi: https://doi.org/10.1101/2020.08.10.20171371
Ling Ni
1Institute for Immunology and School of Medicine, Tsinghua University, Beijing 100084, China
2Center for Human Disease Immuno-monitoring, Beijing Friendship Hospital, Beijing 100050, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meng-Li Cheng
3College of Basic Medical Science, Jilin University, Changchun 130021, China
4Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hui Zhao
4Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yu Feng
1Institute for Immunology and School of Medicine, Tsinghua University, Beijing 100084, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jingyuan Liu
5Beijing Ditan Hospital, Capital Medical University, and Beijing Key Laboratory of Emerging Infectious Diseases, Beijing100015, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fang Ye
6Department of Hematology, Chui Yang Liu Hospital affiliated to Tsinghua University, Beijing 100022, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qing Ye
4Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gengzhen Zhu
1Institute for Immunology and School of Medicine, Tsinghua University, Beijing 100084, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaoli Li
1Institute for Immunology and School of Medicine, Tsinghua University, Beijing 100084, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pengzhi Wang
1Institute for Immunology and School of Medicine, Tsinghua University, Beijing 100084, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jing Shao
1Institute for Immunology and School of Medicine, Tsinghua University, Beijing 100084, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yong-Qiang Deng
4Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peng Wei
1Institute for Immunology and School of Medicine, Tsinghua University, Beijing 100084, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fang Chen
7Department of Cardiology, Chui Yang Liu Hospital affiliated to Tsinghua University, Beijing100022, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cheng-Feng Qin
4Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guoqing Wang
3College of Basic Medical Science, Jilin University, Changchun 130021, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fan Li
3College of Basic Medical Science, Jilin University, Changchun 130021, China
8China-Japan Union Hospital, Jilin University, Changchun 130033, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: chendong@tsinghua.edu.cn zenghui@ccmu.edu.cn lifan@jlu.edu.cn
Hui Zeng
5Beijing Ditan Hospital, Capital Medical University, and Beijing Key Laboratory of Emerging Infectious Diseases, Beijing100015, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: chendong@tsinghua.edu.cn zenghui@ccmu.edu.cn lifan@jlu.edu.cn
Chen Dong
1Institute for Immunology and School of Medicine, Tsinghua University, Beijing 100084, China
2Center for Human Disease Immuno-monitoring, Beijing Friendship Hospital, Beijing 100050, China
9Beijing Key Lab for Immunological Research on Chronic Diseases, Beijing 100084, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: chendong@tsinghua.edu.cn zenghui@ccmu.edu.cn lifan@jlu.edu.cn
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

SUMMARY

The World Health Organization has declared SARS-CoV-2 virus outbreak a world-wide pandemic. Individuals infected by the virus exhibited different degrees of symptoms, the basis of which remains largely unclear. Currently, though convalescent individuals have been shown with both cellular and humoral immune responses, there is very limited understanding on the immune responses, especially adaptive immune responses, in patients with severe COVID-19. Here, we examined 10 blood samples from COVID-19 patients with acute respiratory distress syndrome (ARDS). The majority of them (70%) mounted SARS-CoV-2-specific humoral immunity with production of neutralizing antibodies. However, compared to healthy controls, the percentages and absolute numbers of both NK cells and CD8+ T cells were significantly reduced, accompanied with decreased IFNγ expression in CD4+ T cells in peripheral blood from severe patients. Most notably, we failed in detecting SARS-CoV-2-specific IFNγ production by peripheral blood lymphocytes from these patients. Our work thus indicates that COVID-19 patients with severe symptoms are associated with defective cellular immunity, which not only provides insights on understanding the pathogenesis of COVID-19, but also has implications in developing an effective vaccine to SARS-CoV-2.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported in part by grants from the National Key Research and Development Program of China (2016YFC0906200 to CD, 2016YFC130390 to LN , and 2020YFA0707800 to XW), Natural Science Foundation of China (31991173, 31821003 and 31991170 to CD), Beijing Municipal Science and Technology (Z181100001318007, Z181100006318015 and Z171100000417005 to C.D.), Zhejiang University Foundation (2020XGZX014 to CD), Tsinghua University (to CD) and Science and Technology Development Plan Project of Jilin Province (20200901007SF to F.L.).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Institution review board of Tsinghua Univeristy Project title" Detection of virus-specific antibodies and CTL in patients with COVID-19" was approved on Feb 26,2020.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

all the data referred to in the manuscript are available.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted August 12, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Impaired cellular immunity to SARS-CoV-2 in severe COVID-19 patients
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Impaired cellular immunity to SARS-CoV-2 in severe COVID-19 patients
Ling Ni, Meng-Li Cheng, Hui Zhao, Yu Feng, Jingyuan Liu, Fang Ye, Qing Ye, Gengzhen Zhu, Xiaoli Li, Pengzhi Wang, Jing Shao, Yong-Qiang Deng, Peng Wei, Fang Chen, Cheng-Feng Qin, Guoqing Wang, Fan Li, Hui Zeng, Chen Dong
medRxiv 2020.08.10.20171371; doi: https://doi.org/10.1101/2020.08.10.20171371
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Impaired cellular immunity to SARS-CoV-2 in severe COVID-19 patients
Ling Ni, Meng-Li Cheng, Hui Zhao, Yu Feng, Jingyuan Liu, Fang Ye, Qing Ye, Gengzhen Zhu, Xiaoli Li, Pengzhi Wang, Jing Shao, Yong-Qiang Deng, Peng Wei, Fang Chen, Cheng-Feng Qin, Guoqing Wang, Fan Li, Hui Zeng, Chen Dong
medRxiv 2020.08.10.20171371; doi: https://doi.org/10.1101/2020.08.10.20171371

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Allergy and Immunology
Subject Areas
All Articles
  • Addiction Medicine (161)
  • Allergy and Immunology (414)
  • Anesthesia (90)
  • Cardiovascular Medicine (857)
  • Dentistry and Oral Medicine (159)
  • Dermatology (97)
  • Emergency Medicine (248)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (393)
  • Epidemiology (8557)
  • Forensic Medicine (4)
  • Gastroenterology (383)
  • Genetic and Genomic Medicine (1749)
  • Geriatric Medicine (167)
  • Health Economics (372)
  • Health Informatics (1239)
  • Health Policy (620)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (372)
  • Infectious Diseases (except HIV/AIDS) (10292)
  • Intensive Care and Critical Care Medicine (553)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (211)
  • Neurology (1676)
  • Nursing (97)
  • Nutrition (249)
  • Obstetrics and Gynecology (326)
  • Occupational and Environmental Health (450)
  • Oncology (928)
  • Ophthalmology (263)
  • Orthopedics (101)
  • Otolaryngology (172)
  • Pain Medicine (112)
  • Palliative Medicine (40)
  • Pathology (252)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (248)
  • Primary Care Research (207)
  • Psychiatry and Clinical Psychology (1765)
  • Public and Global Health (3835)
  • Radiology and Imaging (623)
  • Rehabilitation Medicine and Physical Therapy (320)
  • Respiratory Medicine (520)
  • Rheumatology (208)
  • Sexual and Reproductive Health (166)
  • Sports Medicine (158)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)